Pharma Faces / Anna Wienner, IBSA Hungary
As general manager of the Hungarian affiliate of Swiss firm IBSA, Anna Wienner has proven herself to be a motivated pharma leader with particular expertise in reshaping and building organizations.…
USA / The Healthcare Insurance Industry Hits Back
In 2019, several drug companies testified to the US Senate Finance Committee on medicine price hikes with a narrative of discounts given to health insurance companies and pharmacists, but not…
MEA / Gulf Healthcare Costs to Rise Drastically in 2020
Growing incidence of lifestyle-related diseases, coupled with high drug prices, are driving up healthcare costs at astounding rates in the Middle East and North Africa, with experts urging preventative measures…
UAE / Becoming a Global Pharma Management Hub
From Turkey to Tajikistan, Bangladesh to Bahrain, and Russia to Rwanda, multinational pharma firms are increasingly situating wide-ranging management responsibilities in the UAE. The following is an inexhaustive list of…
Talent / Mexican Pharma: Where Are They Now?
Between 2015 and 2017 PharmaBoardroom met with pharma country managers in Mexico who spoke about the challenges and opportunities present in the Mexican market. Since then, these five stakeholders have…
Coronavirus / France’s Institut Pasteur; On Course to Develop a Vaccine?
Researchers at the Institut Pasteur in Paris have become the first in Europe to fully sequence the genome of the 2019-nCoV coronavirus – putting the Institut at the forefront of…
China / The Rise of Chinese Biosimilars
The Chinese healthcare market has transformed dramatically in the past few years. There have been many reforms centred around the country’s vision of becoming a healthcare technology powerhouse in the…
Consumer Healthcare / Consolidation & Digitalization in the Czech Pharmacy Sector: New Strategies Needed
Increasing consolidation and digitalization within the Czech pharmacy sector is forcing consumer healthcare firms to rethink their strategies. Pharmacy Consolidation Within the Central and Eastern European (CEE) region, the…
Opinion / Bringing Patient Experience to Regulatory Decision-Making: Communication Pathway Needed
Takeda’s Jessica S. Scott examines the steps already being taken to bring greater patient engagement to drug development and the regulatory decision-making process in the USA; as well as what…
News Roundup / Indian Pharma: January 2020
Below is a selection of the top stories in Indian pharma from recent months, ranging from efforts to counter the coronavirus, to regulatory reform, the spike in USFDA warning letters…
Manufacturing / UCB’s Latest Belgian Investment
After reaching revenues of EUR 2.323 billion in the first six months of 2019, UCB announced on December 18 that it will build an innovative multi-product biological manufacturing facility on…
European Cancer Forum 2020 / Belgian MoH Maggie De Block Delivers Strong Message on Access to Innovation
The second edition of the European Cancer Forum was held in Brussels, Belgium on Tuesday, 29 January 2020. Hosted by MSD in collaboration with the European Cancer Patient Coalition (ECPC),…